PROCEPT BioRobotics Statistics
Share Statistics
PROCEPT BioRobotics has 55.33M
shares outstanding. The number of shares has increased by 6.6%
in one year.
| Shares Outstanding | 55.33M |
| Shares Change (YoY) | 6.6% |
| Shares Change (QoQ) | 0.78% |
| Owned by Institutions (%) | 96.78% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 683 |
| FTD / Avg. Volume | 0.07% |
Short Selling Information
The latest short interest is 5.9M, so 10.76% of the outstanding
shares have been sold short.
| Short Interest | 5.9M |
| Short % of Shares Out | 10.76% |
| Short % of Float | 14.48% |
| Short Ratio (days to cover) | 7.17 |
Valuation Ratios
The PE ratio is -45.91 and the forward
PE ratio is -54.15.
PROCEPT BioRobotics's PEG ratio is
2.1.
| PE Ratio | -45.91 |
| Forward PE | -54.15 |
| PS Ratio | 18.7 |
| Forward PS | 4.6 |
| PB Ratio | 10.43 |
| P/FCF Ratio | -40.5 |
| PEG Ratio | 2.1 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for PROCEPT BioRobotics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.07,
with a Debt / Equity ratio of 0.2.
| Current Ratio | 9.07 |
| Quick Ratio | 8.01 |
| Debt / Equity | 0.2 |
| Debt / EBITDA | -0.98 |
| Debt / FCF | -0.77 |
| Interest Coverage | -23.09 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $296,955.03 |
| Profits Per Employee | $-120,916.67 |
| Employee Count | 756 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.56 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -12.7% in the
last 52 weeks. The beta is 1.1, so PROCEPT BioRobotics's
price volatility has been higher than the market average.
| Beta | 1.1 |
| 52-Week Price Change | -12.7% |
| 50-Day Moving Average | 55.61 |
| 200-Day Moving Average | 72.39 |
| Relative Strength Index (RSI) | 54.17 |
| Average Volume (20 Days) | 1,007,919 |
Income Statement
In the last 12 months, PROCEPT BioRobotics had revenue of 224.5M
and earned -91.41M
in profits. Earnings per share was -1.75.
| Revenue | 224.5M |
| Gross Profit | 137.1M |
| Operating Income | -96.61M |
| Net Income | -91.41M |
| EBITDA | -82M |
| EBIT | -87.23M |
| Earnings Per Share (EPS) | -1.75 |
Full Income StatementBalance Sheet
The company has 333.73M in cash and 80.25M in
debt, giving a net cash position of 253.47M.
| Cash & Cash Equivalents | 333.73M |
| Total Debt | 80.25M |
| Net Cash | 253.47M |
| Retained Earnings | -545.99M |
| Total Assets | 519.38M |
| Working Capital | 413.73M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -99.21M
and capital expenditures -4.41M, giving a free cash flow of -103.62M.
| Operating Cash Flow | -99.21M |
| Capital Expenditures | -4.41M |
| Free Cash Flow | -103.62M |
| FCF Per Share | -1.99 |
Full Cash Flow StatementMargins
Gross margin is 61.07%, with operating and profit margins of -43.04% and -40.72%.
| Gross Margin | 61.07% |
| Operating Margin | -43.04% |
| Pretax Margin | -40.72% |
| Profit Margin | -40.72% |
| EBITDA Margin | -36.52% |
| EBIT Margin | -43.04% |
| FCF Margin | -46.16% |
